Preventive genetic test against Alzheimer’s disease

The BRAINgen test analyzes genetic polymorphisms known to be involved in the development of Alzheimer’s disease as well as its possible underlying causes such as lipid metabolic disorders, inflammation processes and other independent disorders involved in other metabolic pathways.

BRAINgen allows to reduce the relative risk by preventive measures.

This test is carried out on a sub-contracted basis by an accredited laboratory.



Metabolic disorders


Mental health, stress, fatigue